“EIFL and partner consortia in Kenya, Lesotho, Lithuania, Uganda and Zimbabwe joined over 250 organizations, prominent researchers and copyright experts calling for a reduction of copyright barriers to COVID-19 prevention, containment and treatment at the World Trade Organization (WTO).
The statement by global civil society groups and prominent researchers focuses particular attention on the need to include copyright rules within the waiver….”
“We support the work and interests of millions of researchers, educators, libraries, archives and museums around the world who are contributing to the prevention, containment and treatment of the COVID-19 pandemic through promotion of access to knowledge. We applaud the efforts of World Trade Organization (WTO) Members to address copyright barriers to an equitable response to COVID-19. Access to copyrighted works, in addition to patents and know-how, is needed to prevent and contain COVID-19 and to develop treatments. COVID-19 has aggravated deep inequalities in access to knowledge. In some countries with flexible copyright systems, residents are able to access and use essential materials in remote educational, learning and research activities, virtually access and use the collections of libraries and other institutions, and contribute to research on treatments using advanced processes such as text and data mining. But these activities are not taking place everywhere because they are not lawful everywhere….”
“Over the last 40 years or so, a complex web of international legal agreements was developed that regulate the access, transfer, and use of plant genetic resources. These include the Convention on Biological Diversity (CBD), the Nagoya Protocol, and the International Treaty on Plant Genetic Resources (Figure 1). In developing these legal regimes, policy makers struggled to balance a number of conflicting demands. These included ensuring that access providers share in the benefits that arise from the use of their genetic resources; that users who value-add to genetic resources can protect their innovations via intellectual property; and, at the same time, that scientists and breeders have ongoing access to genetic resources. While there are problems with the existing regimes, they have reached an uneasy compromise of sorts….”
“EIFL and IFLA (the International Federation of Library Associations and Institutions) have called on the Members of the World Trade Organization (WTO) to extend international trade law measures which reduce burdens on the poorest countries, and allow them to set regulatory frameworks for copyright to enable their libraries to support education, research and cultural participation….
The meeting, that takes place on 10-11 March 2021, will discuss, among other issues, a request by Least Developed Countries (LDCs) to extend an exemption for LDCs from implementing the substantive obligations for protection and enforcement of IP rights, including copyright, in the TRIPS Agreement….
For the library community, it [extending the exemption] would have the practical effect of enabling governments freely to craft modern copyright exceptions to maximize possibilities to use copyright-protected content for education, research and innovation, without fear of sanction. For example, it would facilitate classroom use and online education, support world-class research, and enable the use of digital tools, such as text and data mining (TDM) for medical and scientific discovery….”
“Ever so softly, European politicians are beginning to voice a once unthinkable threat by suggesting they could snatch patents from drug companies to make up for massive shortfalls in the supply of coronavirus vaccines.
Big Pharma businesses have for many years regarded EU countries as unquestioningly loyal allies over intellectual property rights in the international trade arena. The EU could always be relied upon to defend U.S., Japanese and European drugmakers from poor nations in Africa and South Asia that have long wanted the recipe of critical medicines to be handed over to generic manufacturers.
But fury over the inability of companies to deliver on contracts amid the COVID-19 pandemic means that now even European politicians, from the Italian parliament to German Economy Minister Peter Altmaier, are arguing, albeit cautiously, that patents may no longer be as sacrosanct as they once were….”
“There aren’t enough vaccines to go around in the richest countries on earth, let alone the poorest ones.
That’s why it makes little sense that the United States, Britain and the European Union, among others, are blocking a proposal at the World Trade Organization that would allow them, and the rest of the world, to get more of the vaccines and treatments we all need.
The proposal, put forward by India and South Africa in October, calls on the W.T.O. to exempt member countries from enforcing some patents, trade secrets or pharmaceutical monopolies under the organization’s agreement on trade-related intellectual property rights, known as TRIPs….”
Abstract. In this article, the authors analyze the legal regulation of the copyright protection of the results of scientific activity in Russia, the United States and the countries of the Near East. Considerable attention is paid to the review of key regulatory acts of the states operating in the designated area, as well as international treaties affecting aspects of the copyright protection of intellectual rights in the field of science. The authors consider the main ways of protecting the scientific results by means of copyright. Special attention is paid to the analysis of the judicial practice of the states, which plays a vital role in defining approaches to the legal regulation of the scientific results. The authors emphasized the similarity and difference between the systems of copyright protection of the results of scientific activity, the role of the judiciary in the functioning of such systems. In the end the conclusion is made about the prospects for harmonization of the approaches to the legal regulation of the results of scientific activity by means of copyright. The article will be relevant to practicing lawyers, researchers, students and everyone who is interested in IP law.
“Hundreds of Native American treaties have been scanned and are freely available online, for the first time, through the National Archives Catalog. Also, in partnership with The Museum of Indian Arts and Culture (MIAC), these treaties and extensive additional historical and contextual information are available through Treaties Explorer (or DigiTreaties). …”
“The Marrakesh Treaty is an international treaty that seeks to facilitate access to published works for people who are blind, visually impaired or have other difficulties in accessing printed text. It is the first international copyright treaty that focuses on users of intellectual works and not exclusively on authors. It was adopted on June 27, 2013 in Morocco and its main objective is to guide countries in the creation of copyright flexibilities for the benefit of people with disabilities and difficulty in conventional reading. This article explores the impact of the Marrakesh Treaty and considers how to expand its benefits….”
“Intellectual property (IP) rights can potentially impede mass production of existing health products, as well as innovation and research and development of new products. IP rights can be exercised by their owners to grant or withhold from licensing the technology required for manufacturing or further developing a product. If a license is denied, the technology will not be available for other firms to manufacture or supply.
Usually, a bundle of several IP rights can exist around a particular technology. It is very common patenting strategy in the pharmaceutical industry to take separate patents on the main compound of a drug and a large number of secondary patents on different formulations and combinations, dosage, as well as other possible therapeutic use of a drug. This can make it difficult for follow on innovators to invent around the thicket of IP rights….
Through a resolution of the World Health Assembly on COVID-19, member states of the WHO have recognised the possible need for countries to adopt measures to ensure that IP rights do not constrain global equitable access to health technologies for COVID-19 through the full use of the flexibilities of the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) as well as voluntary pooling of patented technologies, data and know-how….
A number of flexibilities available under the TRIPS Agreement can be applied by governments to ensure that IP rights do not constrain innovation and availability of health technologies required for responding to COVID-19….
It is time for developing countries to review the extent to which such measures can be adopted, or what changes, if any, need to be introduced into their legal regimes so as to be able to act effectively and timely to address the devastating effects of the COVID-19 pandemic….”